The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with ...

After nearly a decade of machine learning innovations, the FDA has issued its first draft guidance on the use of AI in drug ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

Lundbeck’s drug portfolio faces patent expirations but shows growth potential. Find out why HLBBF stock could see upside with ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

Recognizing the increased use of artificial intelligence in the development of new therapies, the U.S. FDA on Monday released ...

The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...